ArticlePHAGE (New Rochelle, N.Y.)2025
Article in PHAGE (New Rochelle, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Genomic sequencing and annotation, morphological characterization, and host range analyses of bacteriophage (phage) isolates are crucial to understanding each phage's unique set of properties and how they can be utilized as effective tools in medicine, environmental monitoring, biotechnology, and agriculture. In this study, we present the fully annotated genome of viral isolate Materials and Methods: Whole genome sequencing, Results: NRG-P0073 was found to have a 170,913 bp genome, coding for 10 tRNAs, 14 terminators, 259 genes, 249 coding sequences, and a GC content of 35.5%. Double-agar spot tests revealed that NRG-P0073 could adsorb 33 of the 72 strains (45.8%), but only 15 of the 72 strains (20.8%) could complete replication to form distinguishable plaques. All nine of the Conclusions: This study presents novel and complete genomic data, characterization, and host range analyses for the newly characterized phage NRG-P0073. Further characterization and analysis are required, including the identification of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.